index: hide
name: Table 3
title: Table 3. Maximum Dose Constraints for SABR*

| OAR/Regimen | 1 Fraction | 3 Fractions | 4 Fractions | 5 Fractions |
|-------------|------------|-------------|-------------|-------------|
| Spinal cord | 14 Gy | 18 Gy (6 Gy/fx) | 26 Gy (6.5 Gy/fx) | 30 Gy (6 Gy/fx) |
| Esophagus | 15.4 Gy | 27 Gy (9 Gy/fx) | 30 Gy (7.5 Gy/fx) | 105% of PTV prescription^ |
| Brachial plexus | 17.5 Gy | 24 Gy (8 Gy/fx) | 27.2 Gy (6.8 Gy/fx) | 32 Gy (6.4 Gy/fx) |
| Heart/ pericardium | 22 Gy | 30 Gy (10 Gy/fx) | 34 Gy (8.5 Gy/fx) | 105% of PTV prescription^ |
| Great vessels | 37 Gy | NS | 49 Gy (12.25 Gy/fx) | 105% of PTV prescription^ |
| Trachea & proximal bronchi | 20.2 Gy | 30 Gy (10 Gy/fx) | 34.8 Gy (8.7 Gy/fx) | 105% of PTV prescription^ |
| Rib | 30 Gy | 30 Gy (10 Gy/fx) | 40 Gy (10 Gy/fx) | NS |
| Skin | 26 Gy | 24 Gy (8 Gy/fx) | 36 Gy (9 Gy/fx) | 32 Gy (6.4 Gy/fx) |
| Stomach | 12.4 Gy | NS | 27.2 Gy (6.8 Gy/fx) | NS |

\*Based on constraints used in recent RTOG SABR trials (RTOG 0618, 0813, & 0915).
^for central tumor location. NS = not specified

Please note - Tables 2â€“4 provide doses and constraints used commonly or in past clinical trials as useful references rather than specific recommendations.
